Prepn: A. J. Ewins et al., GB 507565 (1939 to May & Baker); J. N. Ashley et al., J. Chem. Soc. 1942, 103; of isethionate: G. Newbery, A. P. T. Easson: US 2394003 (1946 to May & Baker). Trypanocidal activity: E. M. Lourie, W. Yorke, Ann. Trop. Med. Parasitol. 33, 289 (1939). Preliminary pharmacology: R. Wien, ibid. 37, 1 (1943). Determn in biological fluids: D. P. Jackson et al., J. Biol. Chem. 167, 377 (1947). Mode of action: M. J. Pine, Biochem. Pharmacol. 17, 75 (1968). Activity in fibrinolytic systems: J. D. Geratz, Thromb. Diath. Haemorrh. 29, 154 (1973). Clinical use in treatment of Acanthamoeba keratitis: D. L. Easty, Br. Med. J. 296, 228 (1988); J. J. Wiens, W. B. Jackson, Can. J. Ophthalmol. 23, 107 (1988). Early review of pharmacology, mode of action and clinical applications: E. B. Schoenbach, E. M. Greenspan, Medicine 27, 327-377 (1948).
Antiprotozoal (Trypanosoma); antiamebic.
Antiamebic; Antiprotozoal (Trypanosoma)